|
FY2026
12 months to Jul 31, 2026
|
FY2025
12 months to Jul 31, 2025
|
FY2024
12 months to Jul 31, 2024
|
FY2023
12 months to Jul 31, 2023
|
FY2022
12 months to Jul 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Share-based compensation for equity-based awards | |||||
| Deferred income taxes | |||||
| Depreciation and amortization | |||||
| Amortization of deferred contract costs | |||||
| Amortization of debt issuance costs | |||||
| Change in fair value of convertible senior notes and capped calls | |||||
| Change in fair value of contingent consideration liability | |||||
| Reduction of operating lease right-of-use assets | |||||
| Amortization of investment premiums, net of accretion of purchase discounts | |||||
| Unrealized foreign currency exchange (gains) losses, net | |||||
| Changes in operating assets and liabilities, net of effects of acquisitions: | |||||
| Accounts receivable, net | |||||
| Financing receivables, net | |||||
| Deferred contract costs | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Accrued and other liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of investments | |||||
| Proceeds from sales of investments | |||||
| Proceeds from maturities of investments | |||||
| Business acquisitions, net of cash and restricted cash acquired | |||||
| Purchases of property, equipment, and other assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Repayments and settlement of conversions of convertible senior notes | |||||
| Proceeds from capped calls related to convertible senior notes | |||||
| Repurchases of common stock | |||||
| Proceeds from sales of shares through employee equity incentive plans | |||||
| Payments for taxes related to net share settlement of equity awards | |||||
| Payments of contingent consideration liability | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash—beginning of period | |||||
| Cash, cash equivalents, and restricted cash—end of period | |||||
| Non-cash investing and financing activities | |||||
| Equity consideration for business acquisitions | |||||
| Contingent consideration for a business acquisition | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for income taxes | |||||
| Cash paid for contractual interest | |||||
| Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in prepaid expenses and other current assets | |||||
| Restricted cash included in other assets | |||||
Loading...